论文部分内容阅读
目的:探究妊高症剖腹产术后宫腔内放米索对于预防产后出血的临床效果。方法:选取本院自2013年7月至2015年7月间在本院进行剖宫产的产妇70例,按照随机双盲法将本组患者随机分成研究组35例和对照组35例,对照组的患者产后予以催产素宫体注射,并且在术后予以静脉滴注维持;研究组的患者产后于宫腔内放米索前列醇。后观察比较两组患者术前、术后血压的变化、术后出血量及不良反应等。结果:研究结果显示,研究组患者术后血压呈下降趋势,对照组患者相对升高,差异具有显著性,P<0.05;且研究组患者产后阴道出血量明显较对照组少,差异具有统计学意义(P<0.05)。而两组患者的不良反应比较差异不具有显著性,(P>0.05)不具有统计学意义。结论:研究表明,于妊高症剖腹产术后向宫腔内放置米索不仅能有效减少产后出血量,并且不良反应较轻,其对于妊高症剖腹产产妇具有重要的价值。
Objective: To investigate the clinical effect of intrauterine discharge of misoprostol in pregnancy induced hypertension after caesarean section on prevention of postpartum hemorrhage. Methods: Seventy women who underwent cesarean section in our hospital from July 2013 to July 2015 were randomly divided into study group (35 cases) and control group (35 cases) according to randomized double-blind method Patients in the group were given oxytocin injection postpartum and were given intravenous infusion after operation. Patients in the study group were given intrauterine misoprostol postpartum. After the observation and comparison of two groups of patients preoperative and postoperative blood pressure changes, postoperative bleeding and adverse reactions. Results: The study showed that the study group patients postoperative blood pressure decreased trend, the control group patients were relatively higher, the difference was significant (P <0.05); and study group patients postpartum vaginal bleeding was significantly less than the control group, the difference was statistically significant Significance (P <0.05). There was no significant difference between the two groups in adverse reactions (P> 0.05), but not statistically significant. Conclusion: The study shows that placement of misoprostol in uterine cavity after cesarean section in pregnancy induced hypertension can not only effectively reduce the amount of postpartum hemorrhage, but also have less adverse reactions, which is of great value for pregnant women with caesarean section.